Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...
Abstract: Multi-view clustering (MVC) has gained attention for its ability to efficiently handle complex high-dimensional data. Many existing MVC methods rely on a technique known as Nonnegative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback